Remimazolam benzenesulfonate is primarily used as a sedative in medical settings, particularly for procedures requiring short-term sedation. It is commonly administered for induction and maintenance of sedation during surgeries or diagnostic procedures like endoscopies. Its rapid onset and short duration of action make it suitable for outpatient procedures, allowing patients to recover quickly with minimal side effects. Additionally, it is often preferred for patients with compromised health due to its favorable safety profile and predictable pharmacokinetics. The drug is also used in intensive care units for short-term sedation of mechanically ventilated patients, ensuring comfort while maintaining the ability to quickly adjust sedation levels as needed.